CCAR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.042400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.560200E-01
Normal-vs-Stage2
2.087800E-01
Normal-vs-Stage3
4.694400E-02
Normal-vs-Stage4
8.094600E-01
Stage1-vs-Stage2
3.181200E-01
Stage1-vs-Stage3
1.231220E-01
Stage1-vs-Stage4
9.906800E-01
Stage2-vs-Stage3
8.314300E-02
Stage2-vs-Stage4
3.998000E-01
Stage3-vs-Stage4
2.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.031000E-01
Normal-vs-AfricanAmerican
6.979200E-01
Normal-vs-Asian
1.355030E-01
Caucasian-vs-AfricanAmerican
3.733600E-01
Caucasian-vs-Asian
2.800800E-01
AfricanAmerican-vs-Asian
2.370400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.062600E-01
Normal-vs-Female
2.236800E-01
Male-vs-Female
9.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.729600E-01
Normal-vs-Age(41-60Yrs)
5.023000E-01
Normal-vs-Age(61-80Yrs)
1.089770E-01
Normal-vs-Age(81-100Yrs)
2.893800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.177400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.021400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.659400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.480500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.394600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.882000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.152020E-01
Normal-vs-Daily Drinker
6.306300E-02
Normal-vs-Weekly Drinker
1.816640E-01
Normal-vs-Occasional Drinker
1.360440E-01
Normal-vs-Social Drinker
2.186200E-01
Non Drinker-vs-Daily Drinker
2.558600E-01
Non Drinker-vs-Weekly Drinker
9.614400E-01
Non Drinker-vs-Occasional Drinker
7.622200E-01
Non Drinker-vs-Social Drinker
3.113800E-01
Daily Drinker-vs-Weekly Drinker
3.477400E-01
Daily Drinker-vs-Occasional Drinker
1.928440E-01
Daily Drinker-vs-Social Drinker
5.945900E-02
Weekly Drinker-vs-Occasional Drinker
8.388200E-01
Weekly Drinker-vs-Social Drinker
4.160400E-01
Occasional Drinker-vs-Social Drinker
4.705600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.835500E-02
Normal-vs-Grade 2
8.422400E-03
Normal-vs-Grade 3
1.336440E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.296790E-01
Grade 1-vs-Grade 3
1.816190E-01
Grade 1-vs-Grade 4
9.835500E-02
Grade 2-vs-Grade 3
9.342000E-01
Grade 2-vs-Grade 4
8.422400E-03
Grade 3-vs-Grade 4
1.336440E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.802200E-02
Normal-vs-NonDiabetic
9.241800E-02
Diabetic-vs-NonDiabetic
1.912770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.998000E-02
Normal-vs-NoPancreatitis
7.616500E-02
Pancreatitis-vs-NoPancreatitis
6.332800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.940200E-01
Normal-vs-N1
1.881840E-01
N0-vs-N1
7.916600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.875600E-01
Normal-vs-TP53-NonMutant
4.838200E-01
TP53-Mutant-vs-TP53-NonMutant
6.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
